DSM Integrated Annual Report 2020

Consolidated cash flow statement (Note 26)

x € million

 

2020

 

2019

 

 

 

 

 

Operating activities

 

 

 

 

Net profit for the year

 

508

 

764

Share of the profit of associates and joint ventures (including discontinued operations)1

 

32

 

(54)

Income tax (including discontinued operations)1

 

129

 

152

Profit before income tax expense (including discontinued operations)1

 

669

 

862

Financial income and expense (including discontinued operations)1

 

67

 

92

Operating profit (including discontinued operations)1

 

736

 

954

Depreciation, amortization and impairments (including discontinued operations)1

 

740

 

632

EBITDA (including discontinued operations)1

 

1,476

 

1,586

 

 

 

 

 

Adjustments for:

 

 

 

 

- (Gain) or loss from disposals

 

4

 

(4)

- Acquisition / divestment related in EBITDA

 

55

 

13

- Change in provisions

 

10

 

26

- Defined benefit plans

 

(13)

 

(39)

Adjustments for EBITDA

 

56

 

(4)

 

 

 

 

 

Income tax received

 

11

 

9

Income tax paid

 

(135)

 

(149)

Share-based compensation

 

29

 

34

Contract settlements and other non-cash items

 

13

 

(70)

Other

 

19

 

(8)

Adjustments for non-EBITDA

 

(63)

 

(184)

Operating cash flow before changes in working capital

 

1,469

 

1,398

 

 

 

 

 

Changes in operating working capital:

 

 

 

 

Inventories

 

(36)

 

114

Trade receivables

 

(4)

 

59

Trade payables

 

48

 

(121)

Changes in inventories, trade receivables and trade payables

 

8

 

52

Changes in non-operating working capital

 

17

 

(65)

Changes in working capital

 

25

 

(13)

Cash provided by operating activities

 

1,494

 

1,385

 

 

 

 

 

Investing activities

 

 

 

 

Capital expenditure for:2

 

 

 

 

- Intangible assets

 

(151)

 

(107)

- Property, plant and equipment

 

(458)

 

(520)

Payments regarding drawing rights

 

(17)

 

(14)

Proceeds from disposal of property, plant and equipment

 

1

 

6

Acquisition of subsidiaries and associates

 

(1,533)

 

(556)

Disposal of subsidiaries, businesses and associates

 

(2)

 

37

Additions to fixed-term deposits

 

(468)

 

(1,195)

Withdrawal from fixed-term deposits

 

1,114

 

1,783

Interest received

 

8

 

10

Other financial assets:

 

 

 

 

- Capital payments and acquisitions

 

(20)

 

(53)

- Dividends received

 

5

 

75

- Additions to loans granted

 

(9)

 

(17)

- Repayment of loans granted

 

1

 

25

- Proceeds from disposals

 

47

 

1

Cash from / (used in) investing activities

 

(1,482)

 

(525)

 

 

 

 

 

Financing activities

 

 

 

 

Capital payments from / to non-controlling interests

 

(30)

 

1

Loans taken up

 

1,123

 

7

Repayment of loans

 

(268)

 

(302)

Payments of lease liabilities

 

(55)

 

(53)

Change in debt to credit institutions

 

(95)

 

57

Dividend paid

 

(289)

 

(291)

Interest paid

 

(54)

 

(57)

Proceeds from reissued treasury shares

 

63

 

180

Repurchase of shares

 

(309)

 

(869)

Other

 

(3)

 

(5)

Cash (used in) / from financing activities

 

83

 

(1,332)

 

 

 

 

 

Change in cash and cash equivalents

 

95

 

(472)

 

 

 

 

 

Cash and cash equivalents at 1 January

 

800

 

1,281

Exchange differences relating to cash held

 

(24)

 

(9)

Cash and cash equivalents at 31 December

 

871

 

800

1

The Consolidated cash flow statement includes an analysis of all cash flows in total, therefore including both continuing and discontinued operations. For the amounts related to discontinued operations split by activities and a reconciliation of profit from continuing operations to total, including discontinued operations, see Note 3 Change in the scope of the consolidation.

2

An amount of €24 million included in capital expenditure was funded by customers (2019: €18 million); all lease payments are recognized as cash used in financing activities.